Arlington Partners’s Zimmer Biomet ZBH Stock Holding History

Arlington Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-976	Closed	-$120K	–	674
2021 Q4	$120K	Hold	976	–	–	0.03%	174
2021 Q3	$139K	Hold	976	–	–	0.04%	144
2021 Q2	$152K	Buy	976 +23	+2%	+$3.73K	0.05%	102
2021 Q1	$148K	Buy	+953	New	+$148K	0.05%	112
2018 Q3	–	Sell	-258	Closed	-$28K	–	226
2018 Q2	$28K	Hold	258	–	–	0.03%	90
2018 Q1	$27K	Buy	+258	New	+$30K	0.03%	96

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arlington Partners's ZBH Position: Q1 2022 in Review

Arlington Partners sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 976 shares — an estimated $120K sold.

Arlington Partners first reported a position in ZBH in Q1 2018 and held it in 6 quarters. The position peaked at $152K in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Arlington Partners reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Arlington Partners sold 976 Zimmer Biomet shares in Q1 2022, an estimated $120K.
Arlington Partners first reported a position in Zimmer Biomet in Q1 2018 and held it in 6 quarters.
Arlington Partners's Zimmer Biomet position peaked at $152K in Q2 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Arlington Partners's 13F filing for Q1 2022, filed 14 Apr 2022.